Is Protalix Biotherapeutics Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NYSEMKT: PLX) stock is to Buy PLX stock.
Out of 1 analyst, 0 (0%) are recommending PLX as a Strong Buy, 1 (100%) are recommending PLX as a Buy, 0 (0%) are recommending PLX as a Hold, 0 (0%) are recommending PLX as a Sell, and 0 (0%) are recommending PLX as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year PLX price target, the average PLX price target is $10.00, with the highest PLX stock price forecast at $10.00 and the lowest PLX stock price forecast at $10.00.
The Wall Street analyst predicted that Protalix Biotherapeutics's share price could reach $10.00 by Nov 14, 2024. The average Protalix Biotherapeutics stock price prediction forecasts a potential upside of 769.57% from the current PLX share price of $1.15.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.